• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲地区 1 型糖尿病患儿和青少年的死亡率:以喀麦隆儿童糖尿病变化研究为例。

Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in Cameroon.

机构信息

National Institute for Health Research (NIHR) Global Health Research, University of Exeter Medical School, Exeter, UK.

National Obesity Centre and Endocrinology and Metabolism Diseases Unit, Yaounde Central Hospital, Yaounde, Cameroon.

出版信息

Pediatr Diabetes. 2022 Feb;23(1):33-37. doi: 10.1111/pedi.13294. Epub 2021 Nov 29.

DOI:10.1111/pedi.13294
PMID:34820965
Abstract

INTRODUCTION

Type 1 diabetes in Africa has been associated with high mortality attributed mainly to poor insulin access. Free insulin provision programs for people with type 1 diabetes have been introduced across Africa recently. We aimed to determine the mortality rate and associated factors in a cohort of children and adolescents with type 1 diabetes who receive free insulin treatment in sub-Saharan Africa.

METHODS

We conducted a retrospective analysis using the Changing Diabetes in Children (CDiC) medical records in Cameroon between 2011 and 2015.

RESULTS

The overall mortality rate was 33.0 per 1000 person-years (95% CI 25.2-43.2). Most deaths (71.7%) occurred outside of the hospital setting, and the cause of death was known only in 13/53 (24.5%). Mortality was substantially higher in CDiC participants followed up in regional clinics compared to the main urban CDiC clinic in Yaounde; 41 per 1000 years (95% CI 30.8-56.0) versus 17.5 per 1000 years (95% CI 9.4-32.5), and in those with no formal education compared to those who had some level of education; 68.0 per 1000 years (95% CI 45.1-102.2) versus 23.6 per 1000 years (95% CI 16.5-33.8). In Cox proportional multivariable analysis, urban place of care (HR = 0.23, 95% CI 0.09-0.57; p = 0.002) and formal education (HR = 0.42, 95% CI 0.22-0.79; p = 0.007) were independently associated with mortality.

CONCLUSION

Despite free insulin provision, mortality remains high in children and adolescents with type 1 diabetes in Cameroon and is substantially higher in rural settings and those with no formal education.

摘要

引言

非洲的 1 型糖尿病死亡率较高,主要与胰岛素获取不足有关。最近,非洲各地都推出了为 1 型糖尿病患者免费提供胰岛素的计划。我们旨在确定在撒哈拉以南非洲接受免费胰岛素治疗的儿童和青少年 1 型糖尿病患者队列中的死亡率及其相关因素。

方法

我们对喀麦隆 2011 年至 2015 年期间的儿童糖尿病变化(CDiC)医疗记录进行了回顾性分析。

结果

总的死亡率为每 1000 人年 33.0 例(95%CI 25.2-43.2)。大多数死亡(71.7%)发生在医院环境之外,只有 13/53(24.5%)例死亡原因已知。与在雅温得主要城市 CDiC 诊所接受随访的参与者相比,在区域诊所接受随访的 CDiC 参与者的死亡率要高得多;每 1000 人年 41.0 例(95%CI 30.8-56.0)与每 1000 人年 17.5 例(95%CI 9.4-32.5),与未接受正规教育的参与者相比,接受过某种程度教育的参与者的死亡率更高;每 1000 人年 68.0 例(95%CI 45.1-102.2)与每 1000 人年 23.6 例(95%CI 16.5-33.8)。在 Cox 比例多变量分析中,城市治疗地点(HR=0.23,95%CI 0.09-0.57;p=0.002)和正规教育(HR=0.42,95%CI 0.22-0.79;p=0.007)与死亡率独立相关。

结论

尽管提供了免费胰岛素,但喀麦隆的 1 型糖尿病儿童和青少年的死亡率仍然很高,在农村地区和未接受正规教育的人群中死亡率要高得多。

相似文献

1
Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in Cameroon.撒哈拉以南非洲地区 1 型糖尿病患儿和青少年的死亡率:以喀麦隆儿童糖尿病变化研究为例。
Pediatr Diabetes. 2022 Feb;23(1):33-37. doi: 10.1111/pedi.13294. Epub 2021 Nov 29.
2
Predictors of glucose control in children and adolescents with type 1 diabetes: results of a cross-sectional study in Cameroon.喀麦隆1型糖尿病儿童和青少年血糖控制的预测因素:一项横断面研究的结果
BMC Res Notes. 2017 Jun 12;10(1):207. doi: 10.1186/s13104-017-2534-8.
3
Glycemic control and correlates in a group of sub Saharan type 1 diabetes adolescents.一组撒哈拉以南地区1型糖尿病青少年的血糖控制及其相关因素
BMC Res Notes. 2019 Jan 22;12(1):50. doi: 10.1186/s13104-019-4054-1.
4
Impact of a pioneer diabetes camp experience on glycemic control among children and adolescents living with type 1 diabetes in sub-Saharan Africa.先锋糖尿病营体验对撒哈拉以南非洲地区1型糖尿病儿童和青少年血糖控制的影响。
BMC Endocr Disord. 2016 Jan 20;16:5. doi: 10.1186/s12902-016-0086-x.
5
Long-term mortality in outpatients with type 2 diabetes in a reference hospital in Cameroon: a retrospective cohort study.喀麦隆一家参考医院2型糖尿病门诊患者的长期死亡率:一项回顾性队列研究
BMJ Open. 2018 Feb 22;8(2):e019086. doi: 10.1136/bmjopen-2017-019086.
6
Mortality of children aged 5-15 years in a tertiary care center in Yaoundé, Cameroon.喀麦隆雅温得三级护理中心 5-15 岁儿童死亡率。
Arch Pediatr. 2020 Jul;27(5):257-260. doi: 10.1016/j.arcped.2020.05.006. Epub 2020 May 12.
7
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.青少年围生期获得性 HIV 感染者的流行病学特征:跨区域全球队列分析。
PLoS Med. 2018 Mar 1;15(3):e1002514. doi: 10.1371/journal.pmed.1002514. eCollection 2018 Mar.
8
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.喀麦隆中部地区城乡环境下青少年艾滋病毒耐药性的项目质量指标
AIDS Res Ther. 2020 May 12;17(1):14. doi: 10.1186/s12981-020-00270-7.
9
Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.喀麦隆恩孔桑巴地区医院艾滋病护理中的死亡率和失访趋势。
BMC Res Notes. 2013 Dec 5;6:512. doi: 10.1186/1756-0500-6-512.
10
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study.估算撒哈拉以南非洲地区镰状细胞贫血导致儿童死亡的风险:一项回顾性、多中心、病例对照研究。
Lancet Haematol. 2022 Mar;9(3):e208-e216. doi: 10.1016/S2352-3026(22)00004-7.

引用本文的文献

1
ADECA: A Novel Course for Training Paediatric Diabetes Nurse Educators in Sub-Saharan Africa.ADECA:撒哈拉以南非洲地区培训儿科糖尿病护士教育工作者的新课程。
Horm Res Paediatr. 2025 Jun 21:1-9. doi: 10.1159/000546936.
2
Mortality and low C-peptide levels in children and young people diagnosed with type 1 diabetes in Cameroon: a case series from the young-onset diabetes in sub-Saharan Africa study.喀麦隆1型糖尿病确诊儿童及青少年的死亡率与低C肽水平:来自撒哈拉以南非洲青少年发病型糖尿病研究的病例系列
Pan Afr Med J. 2025 Feb 26;50:62. doi: 10.11604/pamj.2025.50.62.46186. eCollection 2025.
3
Barriers to WHO prequalification of similar biotherapeutic insulin.
阻碍世卫组织预认证类似生物治疗性胰岛素。
Bull World Health Organ. 2024 Nov 1;102(11):795-802. doi: 10.2471/BLT.24.291804. Epub 2024 Sep 25.
4
Estimated Sustainable Cost-Based Prices for Diabetes Medicines.糖尿病药物的基于成本的可持续估计价格。
JAMA Netw Open. 2024 Mar 4;7(3):e243474. doi: 10.1001/jamanetworkopen.2024.3474.
5
Interventions to address global inequity in diabetes: international progress.解决全球糖尿病不平等问题的干预措施:国际进展。
Lancet. 2023 Jul 15;402(10397):250-264. doi: 10.1016/S0140-6736(23)00914-5. Epub 2023 Jun 22.
6
Type 1 diabetes in low and middle-income countries - Tanzania a streak of hope.中低收入国家的 1 型糖尿病 - 坦桑尼亚的一线希望。
Front Endocrinol (Lausanne). 2023 Mar 24;14:1043370. doi: 10.3389/fendo.2023.1043370. eCollection 2023.
7
Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.低收入和中等收入国家1型糖尿病的管理:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的卫生系统比较评估
Diabet Med. 2022 Aug;39(8):e14891. doi: 10.1111/dme.14891. Epub 2022 Jun 6.